{"id":14594,"date":"2023-08-17T10:16:00","date_gmt":"2023-08-17T04:46:00","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=14594"},"modified":"2026-07-23T15:27:48","modified_gmt":"2026-07-23T09:57:48","slug":"til-based-therapies-the-future-of-cancer-immunotherapies","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/","title":{"rendered":"TIL Cell Therapy: Future of Cancer Immunotherapies"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Cancer is known to be one of the leading causes of deaths worldwide. In fact, as per the WHO, close to 10 million cancer related deaths were reported in 2020. Further, it is estimated that, by the end of 2040, 27.5 million new cancer cases will be added to the global numbers, exerting tremendous physical, emotional and financial strain on affected individuals, their families, communities and national health systems. Although there are several treatment options available to control disease progression and keep malignant cells from spreading throughout the body, lasting remission is difficult to achieve. In this context, immunotherapies, a relatively recent addition to the gamut of anticancer interventions, have demonstrated significant promise. Given the limitations associated with conventional cancer treatment options, there has been a surge in the need for more effective, safe and versatile alternatives, such as the TIL cell therapy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>TIL Cell Therapy \u2013 Current Market Landscape<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The TIL cell therapy landscape features, close to 30 companies, across the globe claiming to be actively evaluating <a href=\"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies\/\">TIL therapies<\/a> to treat advance, incurable oncological disorders. The contemporary <a href=\"https:\/\/www.rootsanalysis.com\/reports\/til-therapies-market.html\">TIL  therapies market<\/a> is characterized by a healthy and growing pipeline of more than 75 candidate therapies. More than 95% of the TIL cell therapy candidates, which are being developed to target a wide range of disease indications are autologous in nature.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"944\" height=\"454\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Current-Market-Landscape-for-TIL-based-therapies.webp\" alt=\"Current Market Landscape for TIL based therapies - Roots Analysis\" class=\"wp-image-18202\" style=\"object-fit:contain;width:806px;height:387px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Current-Market-Landscape-for-TIL-based-therapies.webp 944w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Current-Market-Landscape-for-TIL-based-therapies-300x144.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Current-Market-Landscape-for-TIL-based-therapies-768x369.webp 768w\" sizes=\"auto, (max-width: 944px) 100vw, 944px\" \/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\"><strong>TIL Cell Therapy \u2013 Partnerships and Collaborations<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">A growing interest in this field is reflected from the increase in the partnerships focused on R&amp;D, representing close to 40% of the total partnerships, involving both international and indigenous stakeholders. This is followed by licensing deals; most of the licensing deals are focused on the licensing of TIL cell therapy technologies. &nbsp;Majority of such deals were signed between players based in North America.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>TIL-based Therapies \u2013 Funding and Investments<\/strong><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"972\" height=\"458\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Partnerships-and-Collaborations-in-TIL-based-therapies.webp\" alt=\"Partnerships and Collaborations in TIL based therapies - Roots Analysis\" class=\"wp-image-18203\" style=\"object-fit:contain;width:804px;height:378px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Partnerships-and-Collaborations-in-TIL-based-therapies.webp 972w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Partnerships-and-Collaborations-in-TIL-based-therapies-300x141.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Partnerships-and-Collaborations-in-TIL-based-therapies-768x362.webp 768w\" sizes=\"auto, (max-width: 972px) 100vw, 972px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">Several investors, having realized the opportunity within this upcoming segment of <a href=\"https:\/\/www.rootsanalysis.com\/reports\/t-cell-therapies-market\/261.html\">T-cell therapy market<\/a>, have invested USD 2.7 billion, across 30 instances, since 2013. Specifically, in last three years, industry players raised over USD 1.4 billion for the development of these therapies. In addition, majority (37%) of the companies primarily received funding through secondary offering. Further, close to 85% of the total funding instances were reported by players headquartered in the US.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"902\" height=\"427\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Funding-and-Investment-in-TIL-based-therapies.webp\" alt=\"Funding and Investment in TIL based therapies 2023 - Roots Analysis\" class=\"wp-image-18204\" style=\"object-fit:contain;width:804px;height:380px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Funding-and-Investment-in-TIL-based-therapies.webp 902w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Funding-and-Investment-in-TIL-based-therapies-300x142.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Funding-and-Investment-in-TIL-based-therapies-768x364.webp 768w\" sizes=\"auto, (max-width: 902px) 100vw, 902px\" \/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\"><strong>TIL Cell Therapy \u2013 Patent Analysis<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Majority of the patents in this domain are patent applications (72%), followed by granted patents (28%). In addition, most of the patents (60%) were filed \/ granted in North America. This is followed by patents filed \/ granted in Europe.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"975\" height=\"452\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Patent-Analysis-in-the-domain.webp\" alt=\"TIL Therapies \u2013 Patent Analysis - Roots Analysis\" class=\"wp-image-18205\" style=\"object-fit:contain;width:802px;height:371px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Patent-Analysis-in-the-domain.webp 975w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Patent-Analysis-in-the-domain-300x139.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Patent-Analysis-in-the-domain-768x356.webp 768w\" sizes=\"auto, (max-width: 975px) 100vw, 975px\" \/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\"><strong>TIL Cell Therapy \u2013 Market Forecast and Opportunity Analysis<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">In the long-term, the overall projected opportunity is likely to be well distributed across key market segments, including target indications, key players and geographical regions; the <a href=\"https:\/\/www.rootsanalysis.com\/reports\/til-therapies-market.html\">TIL therapies market<\/a> is expected to grow at a CAGR of ~40% by 2035.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"975\" height=\"454\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Market-Forecast-of-TIL-based-therapies.webp\" alt=\"Market Forecast of TIL based therapies 2023 - Roots Analysis\" class=\"wp-image-18207\" style=\"object-fit:contain;width:792px;height:369px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Market-Forecast-of-TIL-based-therapies.webp 975w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Market-Forecast-of-TIL-based-therapies-300x140.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Market-Forecast-of-TIL-based-therapies-768x358.webp 768w\" sizes=\"auto, (max-width: 975px) 100vw, 975px\" \/><\/figure>\n<\/div>\n\n\n<h3 class=\"wp-block-heading\"><strong>Conclusion:<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Owing to their tumor-killing capability and therapeutic superiority, TIL cell therapy is being actively evaluated to treat advance, incurable oncological disorders by various researchers and industry stakeholders. Moreover, the ongoing research activity in this field has led to the discovery of several novel molecular targets, further strengthening the research pipelines of companies engaged in this market. Several clinical trials have proven the efficacy of TIL cell therapy, presenting lucrative opportunities for the players engaged in the development of these products. Driven by a promising development pipeline and encouraging clinical trial results, the TIL therapies market is likely to carve out a significant share of the multi-billion-dollar cancer immunotherapy market.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You can also download the&nbsp;<a href=\"https:\/\/www.rootsanalysis.com\/reports\/til-therapies-market\/request-sample.html\">SAMPLE REPOR<\/a>T&nbsp;on TIL therapies by Roots Analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cancer is known to be one of the leading causes of deaths worldwide. In fact, as per the WHO, close to 10 million cancer related deaths were reported in 2020. Further, it is estimated that, by the end of 2040, 27.5 million new cancer cases will be added to the global numbers, exerting tremendous physical, [&hellip;]<\/p>\n","protected":false},"author":50,"featured_media":16447,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1206,101,118,366],"tags":[263,947,948],"class_list":["post-14594","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer-immunotherapies","category-cell-therapies","category-cell-therapy","category-t-cell-therapies","tag-cancer-therapies","tag-til-therapies","tag-tumor-infiltrating-lymphocytes"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TIL Cell Therapy: The Next Big Leap in Cancer Care<\/title>\n<meta name=\"description\" content=\"According to Roots Analysis, the TIL cell therapy market is expected to witness an annualized growth at a CAGR of ~40% by 2035\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TIL Cell Therapy: The Next Big Leap in Cancer Care\" \/>\n<meta property=\"og:description\" content=\"According to Roots Analysis, the TIL cell therapy market is expected to witness an annualized growth at a CAGR of ~40% by 2035\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-17T04:46:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-23T09:57:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/08\/RootsAnalysis_FeaturedImage_Cancer.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"150\" \/>\n\t<meta property=\"og:image:height\" content=\"150\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Ajay Kumar\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ajay Kumar\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/til-based-therapies-the-future-of-cancer-immunotherapies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/til-based-therapies-the-future-of-cancer-immunotherapies\\\/\"},\"author\":{\"name\":\"Ajay Kumar\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/751675c22a345e40272403a220d0630b\"},\"headline\":\"TIL Cell Therapy: Future of Cancer Immunotherapies\",\"datePublished\":\"2023-08-17T04:46:00+00:00\",\"dateModified\":\"2026-07-23T09:57:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/til-based-therapies-the-future-of-cancer-immunotherapies\\\/\"},\"wordCount\":573,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/til-based-therapies-the-future-of-cancer-immunotherapies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/RootsAnalysis_FeaturedImage_Cancer.webp\",\"keywords\":[\"Cancer Therapies\",\"TIL Therapies\",\"tumor-infiltrating lymphocytes\"],\"articleSection\":[\"Cancer Immunotherapies\",\"Cell Therapies\",\"Cell Therapy\",\"T-Cell Therapies\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/til-based-therapies-the-future-of-cancer-immunotherapies\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/til-based-therapies-the-future-of-cancer-immunotherapies\\\/\",\"name\":\"TIL Cell Therapy: The Next Big Leap in Cancer Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/til-based-therapies-the-future-of-cancer-immunotherapies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/til-based-therapies-the-future-of-cancer-immunotherapies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/RootsAnalysis_FeaturedImage_Cancer.webp\",\"datePublished\":\"2023-08-17T04:46:00+00:00\",\"dateModified\":\"2026-07-23T09:57:48+00:00\",\"description\":\"According to Roots Analysis, the TIL cell therapy market is expected to witness an annualized growth at a CAGR of ~40% by 2035\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/til-based-therapies-the-future-of-cancer-immunotherapies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/til-based-therapies-the-future-of-cancer-immunotherapies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/til-based-therapies-the-future-of-cancer-immunotherapies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/RootsAnalysis_FeaturedImage_Cancer.webp\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/RootsAnalysis_FeaturedImage_Cancer.webp\",\"width\":150,\"height\":150,\"caption\":\"This is a feature image for blog article TIL Therapies at Roots Analysis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/til-based-therapies-the-future-of-cancer-immunotherapies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TIL Cell Therapy: Future of Cancer Immunotherapies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/751675c22a345e40272403a220d0630b\",\"name\":\"Ajay Kumar\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3d808f29b15647a36009a73c9f978f918ced70afffe95e5def5888ce10b9db2c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3d808f29b15647a36009a73c9f978f918ced70afffe95e5def5888ce10b9db2c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3d808f29b15647a36009a73c9f978f918ced70afffe95e5def5888ce10b9db2c?s=96&d=mm&r=g\",\"caption\":\"Ajay Kumar\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TIL Cell Therapy: The Next Big Leap in Cancer Care","description":"According to Roots Analysis, the TIL cell therapy market is expected to witness an annualized growth at a CAGR of ~40% by 2035","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/","og_locale":"en_US","og_type":"article","og_title":"TIL Cell Therapy: The Next Big Leap in Cancer Care","og_description":"According to Roots Analysis, the TIL cell therapy market is expected to witness an annualized growth at a CAGR of ~40% by 2035","og_url":"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2023-08-17T04:46:00+00:00","article_modified_time":"2026-07-23T09:57:48+00:00","og_image":[{"width":150,"height":150,"url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/08\/RootsAnalysis_FeaturedImage_Cancer.webp","type":"image\/webp"}],"author":"Ajay Kumar","twitter_card":"summary_large_image","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Ajay Kumar","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/"},"author":{"name":"Ajay Kumar","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/751675c22a345e40272403a220d0630b"},"headline":"TIL Cell Therapy: Future of Cancer Immunotherapies","datePublished":"2023-08-17T04:46:00+00:00","dateModified":"2026-07-23T09:57:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/"},"wordCount":573,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/08\/RootsAnalysis_FeaturedImage_Cancer.webp","keywords":["Cancer Therapies","TIL Therapies","tumor-infiltrating lymphocytes"],"articleSection":["Cancer Immunotherapies","Cell Therapies","Cell Therapy","T-Cell Therapies"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/","url":"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/","name":"TIL Cell Therapy: The Next Big Leap in Cancer Care","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/08\/RootsAnalysis_FeaturedImage_Cancer.webp","datePublished":"2023-08-17T04:46:00+00:00","dateModified":"2026-07-23T09:57:48+00:00","description":"According to Roots Analysis, the TIL cell therapy market is expected to witness an annualized growth at a CAGR of ~40% by 2035","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/08\/RootsAnalysis_FeaturedImage_Cancer.webp","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/08\/RootsAnalysis_FeaturedImage_Cancer.webp","width":150,"height":150,"caption":"This is a feature image for blog article TIL Therapies at Roots Analysis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/til-based-therapies-the-future-of-cancer-immunotherapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"TIL Cell Therapy: Future of Cancer Immunotherapies"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/751675c22a345e40272403a220d0630b","name":"Ajay Kumar","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/3d808f29b15647a36009a73c9f978f918ced70afffe95e5def5888ce10b9db2c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3d808f29b15647a36009a73c9f978f918ced70afffe95e5def5888ce10b9db2c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3d808f29b15647a36009a73c9f978f918ced70afffe95e5def5888ce10b9db2c?s=96&d=mm&r=g","caption":"Ajay Kumar"}}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/14594","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/50"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=14594"}],"version-history":[{"count":18,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/14594\/revisions"}],"predecessor-version":[{"id":22235,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/14594\/revisions\/22235"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media\/16447"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=14594"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=14594"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=14594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}